Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

LCI
Lannett Company, Inc.
stock NYSE

Inactive
Apr 19, 2023
0.6855USD+3.864%(+0.0255)280,660
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-0.66)0
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
06:52AM EST  LANNETT TO REPORT FISCAL 2022 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE   PR Newswire
Jan 21, 2022
07:39AM EST  Drug maker Lannett Company, Inc. (LCI), said on Friday that the U.S. Food and Drug Administration or FDA has notified the company that it may proceed with its the proposed clinical trials on biosimilar insulin glargine.   RTTNews
07:00AM EST  Lannett Says FDA Completes Review Of IND Application For Biosimilar Insulin Glargine; Stock Surges   RTTNews
06:52AM EST  Lannett Reports FDA Completed Review Of Investigational New Drug Application For Biosimilar Insulin Glargine: 'FDA States Pivotal Clinical Trial May Proceed, Trial Expected to Commence By March 2022'   Benzinga
06:52AM EST  LANNETT ANNOUNCES FDA COMPLETES REVIEW OF INVESTIGATIONAL NEW DRUG (IND)   PR Newswire
Dec 20, 2021
06:56AM EST  Lannett Submits IND With FDA For Pivotal Clinical Trial Of Biosimilar Insulin Glargine   RTTNews
06:54AM EST  Lannett Announces Submission Of Investigational New Drug Application For Biosimilar Insulin Glargine   Benzinga
06:52AM EST  LANNETT ANNOUNCES SUBMISSION OF INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR   PR Newswire
Nov 3, 2021
07:06PM EDT  Lannett Q1 EPS $(0.27) Misses $(0.24) Estimate, Sales $101.53M Beat $98.60M Estimate   Benzinga
07:03PM EDT  Lannett Sees FY22 Sales $370M-$400M Vs $430.15M Est   Benzinga
07:03PM EDT  Lannett Q1 Adj. EPS $(0.27) Misses $(0.24) Estimate, Sales $101.53M Beat $98.60M Estimate   Benzinga
04:16PM EDT  Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down   PR Newswire
09:10AM EDT  Earnings Scheduled For November 3, 2021   Benzinga
Nov 2, 2021
10:52AM EDT  UPDATE: LCI Industries Reports Q3 Adj. EPS $2.50 Beats $2.47 Est.   Benzinga
Oct 28, 2021
06:52AM EDT  Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference   PR Newswire
Aug 31, 2021
08:54AM EDT  Roth Capital Maintains Neutral on Lannett, Lowers Price Target to $6   Benzinga
Aug 30, 2021
06:54AM EDT  Lannett Begins Marketing Mycophenolate Mofetil For Oral Suspension USP, 200 Mg/mL   RTTNews
06:52AM EDT  Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension   PR Newswire
Aug 26, 2021
10:02AM EDT  Recap: Lannett Q4 Earnings   Benzinga
Aug 25, 2021
04:19PM EDT  Lannett Sees FY22 Sales $400M-$440M vs $483.42M Est.   Benzinga
04:17PM EDT  Lannett Q4 EPS $(0.19) Misses $(0.12) Estimate, Sales $106.00M Miss $110.63M Estimate   Benzinga
04:15PM EDT  Lannett Announces Fiscal 2021 Fourth-Quarter, Full-Year Financial Results   PR Newswire
04:03AM EDT  Earnings Scheduled For August 25, 2021   Benzinga
Aug 20, 2021
07:50AM EDT  Lannett's Debt Overview   Benzinga
Aug 18, 2021
11:43AM EDT  Lannett Option Alert: Mar 18 $3 Calls Sweep (30) near the Ask: 200 @ $1.851 vs 4 OI; Earnings 8/30 After Close [est] Ref=$4.22   Benzinga
06:52AM EDT  Lannett To Report Fiscal 2021 Fourth-quarter, Full-year Financial Results, Host   PR Newswire
Aug 12, 2021
05:26AM EDT  Lannett One of Several Companies Receiving FDA REMS Approval on Wednesday for ANDA for Mycophenolate Mofetil   Benzinga
Jul 29, 2021
07:09AM EDT  Lannett Expands Respiratory Pipeline, Signs Exclusive Distribution Agreement For Generic Spiriva Handihaler   Benzinga
06:54AM EDT  LANNETT Signs Exclusive Distribution Agreement For Generic SPIRIVA Handihaler   RTTNews
06:52AM EDT  LANNETT expands respiratory pipeline, signs exclusive distribution agreement   PR Newswire
Jul 12, 2021
06:54AM EDT  Lannett Launches Fluvastatin Sodium ER Tablets   RTTNews
Jun 14, 2021
04:17PM EDT  LCI Industries' Lippert Acquires Trazcor, Inc; No Terms Disclosed   Benzinga
Jun 10, 2021
10:00AM EDT  Roth Capital Maintains Neutral on Lannett, Lowers Price Target to $7   Benzinga
Jun 1, 2021
06:57AM EDT  Lannett Says FDA Accepted ANDA For Fluticasone Propionate And Salmeterol Inhalation Powder   RTTNews
06:54AM EDT  Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic Advair Diskus Filing   Benzinga
06:52AM EDT  Lannett Announces FDA Acceptance, As A Priority Original ANDA, Of The Generic   PR Newswire
May 27, 2021
11:25PM EDT  Organon & Co. (OGN) will be added to the S&P 500 prior to the open of trading on June 3, replacing HollyFrontier, which will be removed from the S&P 500 effective prior to the open of trading on June 4, S&P Dow Jones Indices said in a statement.   RTTNews
05:48PM EDT  Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service   PR Newswire
May 5, 2021
05:00PM EDT  Lannett Q3 Adj. EPS $0.02 Beats $(0.04) Estimate, Sales $112.40M Miss $116.11M Estimate; Reaffirms FY21 Sales Guidance $480M-$500M vs $492.8M Est.   Benzinga
04:16PM EDT  Lannett Announces Fiscal 2021 Third-Quarter Financial Results   PR Newswire
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 28, 2021
06:53AM EDT  Lannett To Report Fiscal 2021 Third-Quarter Financial Results, Host Conference   PR Newswire
Apr 22, 2021
04:16PM EDT  Lannett Announces Closing Of $350 Million Senior Secured Notes And $190 Million   PR Newswire
Apr 9, 2021
06:54AM EDT  Lannett Announces Pricing Of $350 Mln Senior Secured Notes Due 2026 In A Private Placement To Institutional Buyers   RTTNews
06:52AM EDT  Lannett Announces Pricing Of $350 Million Senior Secured Notes Due 2026   PR Newswire
Apr 6, 2021
07:24AM EDT  Lannett Intends To Offer $350 Mln Senior Notes Due 2026 In A Private Placement To Qualified Institutional Buyers   RTTNews
07:22AM EDT  Lannett Announces Offering Of $350 Million Senior Secured Notes Due 2026   PR Newswire
Apr 1, 2021
08:33AM EDT  Lannett Submits ANDA For Generic ADVAIR DISKUS   Benzinga
Mar 10, 2021
07:01AM EST  Lannett Recently Receivesfeedback From FDA Regarding Biosimilar Insulin Glargine   RTTNews
06:54AM EST  Lannett Receives FDA Feedback On Development Of Biosimilar Insulin Glargine; Co. Says Remains On Track To Submit IND Later This Year   Benzinga
06:52AM EST  Lannett Development Of Biosimilar Insulin Glargine Product Continues To Advance   PR Newswire
Feb 19, 2021
01:15AM EST  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of   PR Newswire
Feb 9, 2021
06:55AM EST  Lannett Adds New Co-development Agreement For Biosimilar Insulin   RTTNews
06:53AM EST  Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin   PR Newswire
Feb 8, 2021
06:55AM EST  Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets; Total US Sales In 2020 Were ~$120M   Benzinga
06:53AM EST  Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets   RTTNews
Feb 4, 2021
03:07PM EST  Mid-Afternoon Market Update: Dow Surges Over 250 Points; Lannett Shares Plummet   Benzinga
12:19PM EST  Mid-Day Market Update: Gold Down 2.5%; Lizhi Shares Spike Higher   Benzinga
10:13AM EST  Mid-Morning Market Update: Markets Open Higher; Bristol-Myers Squibb Profit Beats Estimates   Benzinga
Feb 3, 2021
05:39PM EST  Recap: Lannett Q2 Earnings   Benzinga
04:33PM EST  Lannett Shares Move ~15% Lower After Co. Issued FY21 Guidance Below Estimates   Benzinga
04:20PM EST  Lannett Cuts FY21 Sales Guidance From $520M-$545M To $480M-$500M vs $529.32M Est.   Benzinga
04:18PM EST  Lannett Q2 EPS $0.08, Inline, Sales $133.90M Beat $130.00M Estimate   Benzinga
04:16PM EST  Lannett Announces Fiscal 2021 Second-Quarter Financial Results In Line Or Above   PR Newswire
04:00AM EST  Earnings Scheduled For February 3, 2021   Benzinga
Feb 2, 2021
10:17AM EST  Preview: Lannett's Earnings   Benzinga
Jan 27, 2021
06:52AM EST  Lannett To Report Fiscal 2021 Second-Quarter Financial Results, Host Conference   PR Newswire
Jan 14, 2021
04:45PM EST  Lannett 8-K Shows, As A Result Of Decision To Discontinue Certain Product Lines, Co. Determined Such Decision Represents Triggering Event Under GAAP   Benzinga
Dec 7, 2020
04:19PM EST  Lannett Reports Closing Of $30M Asset-Backed Revolving Credit Facility   Benzinga
04:16PM EST  Lannett Announces New $30 Million Revolving Credit Facility   PR Newswire
Nov 30, 2020
06:55AM EST  Lannett Says It Used Portion Of Existing Cash On Hand To Pay Off Remaining $42 Mln Outstanding Balance Of Term A Loans   RTTNews
06:52AM EST  Lannett Pays Off, In Full, Remaining Term A Loans   PR Newswire
Nov 4, 2020
04:21PM EST  Lannett Q1 Adj. EPS $0.06 Misses $0.10 Estimate, Sales $126.50M Miss $128.96M Estimate   Benzinga
04:16PM EST  Lannett Announces Fiscal 2021 First-quarter Financial Results; Affirms Guidance   PR Newswire
04:41AM EST  Earnings Scheduled For November 4, 2020   Benzinga
Nov 3, 2020
06:56AM EST  Lannett Launches Authorized Generic Of Tirosint   RTTNews
06:52AM EST  Lannett Launches Authorized Generic of Tirosint(r) (Levothyroxine Sodium   PR Newswire
Oct 28, 2020
06:53AM EDT  Lannett To Report Fiscal 2021 First-Quarter Financial Results, Host Conference   PR Newswire
Aug 26, 2020
05:15PM EDT  Lannett: Q4 Earnings Insights   Benzinga
04:33PM EDT  Lannett Q4 Loss/share $0.25 Vs. Loss $0.20 Year Ago   RTTNews
04:19PM EDT  Lannett Sees FY21 Sales $520M-$545M Vs. $542.11M   Benzinga
04:19PM EDT  Lannett Q4 EPS $0.31 Beats $0.29 Estimate, Sales $137.90M Beat $134.26M Estimate   Benzinga
04:16PM EDT  Lannett Announces Fiscal 2020 Fourth-Quarter, Full-Year Financial Results   PR Newswire
04:07AM EDT  Earnings Scheduled For August 26, 2020   Benzinga
Aug 25, 2020
12:00PM EDT  Lannett's Earnings Outlook   Benzinga
Aug 19, 2020
06:52AM EDT  Lannett To Report Fiscal 2020 Fourth-Quarter, Full-Year Financial Results, Host   PR Newswire
Aug 17, 2020
04:31PM EDT  Lannett Announces Notice Of Proposed Settlement And Dismissal With Prejudice Of Derivative Action   Benzinga
04:30PM EDT  Lannett Announces Notice Of Proposed Settlement And Dismissal With Prejudice Of   PR Newswire
07:06AM EDT  Lannett Enters Exclusive US Distribution Deal For Therapeutically Equivalent Generic Of Flovent Diskus Of Respirent   RTTNews
06:54AM EDT  Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent Diskus, Lannett Extends its Exclusive Distribution Agreement with Respirent for Generic ADVAIR DISKUS From 10 to 12 Years   Benzinga
06:52AM EDT  Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(r)   PR Newswire
Aug 3, 2020
06:55AM EDT  Lannett Announces Launch Of FDA Approved Levothyroxine Tablets   Benzinga
Jul 27, 2020
06:57AM EDT  Lannett To Launch Levorphanol Tablets   Benzinga
Jul 23, 2020
06:54AM EDT  Lannett Highlights Launch Of Mexiletine Hydrochloride Capsules, The AB-Rated Generic Equivalent Of Mexitil Capsules From Boehringer Ingelheim   Benzinga
06:52AM EDT  Lannett Launches Mexiletine HCl Capsules   PR Newswire
Jul 17, 2020
05:08AM EDT  64 Biggest Movers From Yesterday   Benzinga
Jul 16, 2020
10:19AM EDT  Shares of Lannett Co. (LCI) have been trading in the range of $4.89 - $15.52 for the past one year, and are currently trading at $5.78, up 64 cents or 12.45% in regular session Thursday morning.   RTTNews
06:58AM EDT  Lannett, Cediprof Sign Interim Supply And Distribution Deal For Cediprof's FDA Approved Levothyroxine Sodium Tablets USP   RTTNews
06:55AM EDT  Lannett And Cediprof Announce Exclusive Distribution Agreement For An Approved   PR Newswire
Jul 13, 2020
06:54AM EDT  Lannett To Reduce Workforce By 80 Positions; Expects Cost Savings In Excess Of $15 Mln Annually   RTTNews
06:54AM EDT  Lannett to Reduce its Workforce by 80, Expects $15M in Annual Cost Savings   Benzinga
06:52AM EDT  Lannett Announces Restructuring, Cost Reduction Initiatives   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC